SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-058237
Filing Date
2015-08-10
Accepted
2015-08-10 16:11:26
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-12052_110q.htm 10-Q 527817
2 EX-31.1 a15-12052_1ex31d1.htm EX-31.1 10007
3 EX-31.2 a15-12052_1ex31d2.htm EX-31.2 9995
4 EX-32.1 a15-12052_1ex32d1.htm EX-32.1 4357
5 EX-32.2 a15-12052_1ex32d2.htm EX-32.2 4356
  Complete submission text file 0001104659-15-058237.txt   3193348

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20150630.xml EX-101.INS 584682
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20150630.xsd EX-101.SCH 33162
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20150630_cal.xml EX-101.CAL 27580
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20150630_def.xml EX-101.DEF 121666
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20150630_lab.xml EX-101.LAB 314928
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20150630_pre.xml EX-101.PRE 236315
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 151040880
SIC: 2834 Pharmaceutical Preparations